Institutional investors monitoring the quantum computing sector will soon have another public market option to consider. IQM Quantum Technologies, a Helsinki-based quantum hardware developer, announced plans to list on both U.S. and Nordic exchanges through a blank check company transaction that values the firm at approximately $1.8 billion.
The transaction with Real Asset Acquisition Corp., a Nasdaq-listed SPAC, represents the latest in a series of quantum computing companies choosing the public markets route. For institutional allocators, this development adds to an expanding universe of investable quantum opportunities, though questions about commercial viability timelines persist across the sector.
Revenue Growth Trajectory
IQM reported $35 million in revenue for 2025 alongside more than $100 million in total bookings. The company expects its cash position to exceed $450 million following the SPAC completion, providing substantial runway for its commercial expansion plans. These financial metrics offer institutional investors concrete performance indicators in a sector often characterized by longer development cycles.
The quantum hardware developer emerged from Finland’s Aalto University and VTT Technical Research in 2018. Since inception, IQM has focused on both on-premises full-stack quantum systems and cloud-based access platforms, serving academic institutions and industrial laboratories globally.
Market Context and Timing
Public quantum computing stocks have experienced notable gains in recent months, driven by increased government investment and signals from major technology companies about approaching quantum advantage milestones. This momentum has attracted renewed institutional attention to the sector, despite the extended timeline for widespread commercial applications.
The timing of IQM’s public market entry coincides with similar moves by competitors. Infleqtion, a neutral-atom quantum company, recently debuted on the New York Stock Exchange via SPAC, while Canada’s Xanadu Quantum Technologies plans a Nasdaq listing by March’s end.
For portfolio construction purposes, these developments create a cluster of quantum exposure opportunities within a relatively short timeframe. Institutional investors must evaluate whether this concentration represents genuine sector maturation or temporary market enthusiasm.
SPAC Structure Considerations
The choice of SPAC structures across multiple quantum companies reflects both the capital requirements of the sector and the current appetite for alternative listing methods. While faster than traditional IPOs, SPAC transactions peaked in 2021 and subsequently generated mixed returns for many institutional investors.
IQM’s approach differs slightly through its dual exchange strategy. Beyond the U.S. listing via American Depositary Shares, the company plans to maintain a Nordic exchange presence. This structure may appeal to European institutional investors seeking regional quantum exposure while accessing global capital markets.
Prior to the SPAC announcement, IQM raised approximately $569 million across multiple funding rounds. The most recent Series B, a $320 million raise led by Ten Eleven Ventures, included participation from Finnish investment firm Tesi and strategic investors including Schwarz Group and SEC-registered entities.
Institutional Investment Framework
For institutional allocators evaluating quantum computing opportunities, IQM presents a European alternative to U.S.-dominated public market options. The company’s revenue base and customer relationships provide more concrete valuation anchors compared to purely research-focused competitors.
Risk management considerations include the sector’s extended commercialization timeline and competitive dynamics among quantum computing approaches. While applications in pharmaceuticals, materials science, and financial modeling show promise, practical deployment remains years away for most use cases.
The quantum computing investment thesis requires balancing transformative potential against execution risk and market timing uncertainty. IQM’s public listing will provide additional performance data points for institutional investors building quantum allocations within technology or thematic portfolios.
Market reception of recent quantum IPOs will likely influence pricing and demand for IQM shares. Institutional investors should monitor trading patterns and analyst coverage development as the sector establishes public market precedents. The company’s dual listing strategy may also create arbitrage considerations across different exchange venues and regulatory environments.
